Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 13, 2021 08:30 ET | Source: Scynexis

SCYNEXIS Announces Hansoh Pharma’s Application to National Medical Products Administration (NMPA) in China for Phase 3 Trial of Ibrexafungerp for Treatment of Vulvovaginal Candidiasis (VVC)

JERSEY CITY, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and...
September 09, 2021 05:00 ET | Source: DKBinnovative

DKBinnovative Named to the Prestigious Inc. 5000 List for the 5th Consecutive Year

FRISCO, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Inc. magazine has ranked DKBinnovative as No. 2,397 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing...
September 08, 2021 08:30 ET | Source: Scynexis

SCYNEXIS to Participate in Upcoming Investor Conferences

JERSEY CITY, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and...
August 17, 2021 09:30 ET | Source: Risk Strategies

Risk Strategies Ranks on the Inc. 5000 List, With Three-Year Revenue Growth of 167% Percent

BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Inc. Magazine today revealed that Risk Strategies, a leading national specialty insurance brokerage and risk management firm, is No. 2374 on its annual Inc....
August 17, 2021 07:42 ET | Source: SecureLink

SecureLink Named One of Inc. 5000’s Fastest-Growing Private Companies in the U.S.

AUSTIN, Texas, Aug. 17, 2021 (GLOBE NEWSWIRE) -- SecureLink, a leader in third-party security, ranked 2645 on Inc. Magazine’s 2021 list of the fastest-growing private companies in the United States....
August 17, 2021 07:00 ET | Source: Intel 471

Intel 471 Named to the 2021 Inc. 5000 Annual List of the Fastest-Growing Companies in America

LEWES, Del., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Intel 471, the premier provider of cybercrime intelligence for leading intelligence, security, and fraud teams, today revealed that it has earned a...
August 16, 2021 08:00 ET | Source: Scynexis

SCYNEXIS Reports Second Quarter 2021 Financial Results and Provides Corporate Update

BREXAFEMME® (ibrexafungerp tablets), the first novel antifungal class drug approved by the U.S. Food and Drug Administration (FDA) in more than 20 years, qualifies for 10 years of regulatory...
August 02, 2021 17:00 ET | Source: Scynexis

SCYNEXIS Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

JERSEY CITY, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and...
July 29, 2021 08:00 ET | Source: Scynexis

SCYNEXIS Announces Two Oral Presentations on Pooled Data from the BREXAFEMME (Ibrexafungerp tablets) Phase 3 VANISH Program Demonstrating Consistent Efficacy in the Treatment for Vaginal Yeast Infections at the IDSOG 2021 Virtual Annual Meeting

The pooled data from two Phase 3 studies (VANISH-303 and VANISH-306) of one-day oral ibrexafungerp reflect a population that overwhelmingly had severe yeast infections, a condition typically treated...
July 12, 2021 08:00 ET | Source: Scynexis

SCYNEXIS Announces Three Oral Presentations of Ibrexafungerp Demonstrating Clinical and In Vitro Activity Against Candida Species at the 31st ECCMID

FURI and CARES presentations show ibrexafungerp’s strong clinical response in difficult-to-treat and refractory fungal infections in the hospital setting including Candida aurisIn vitro data...